Tethis appoints Holger Neecke as the company's Chief Executive Officer
yahoo.com
finance
2022-10-20 07:00:00

MILAN, Oct. 20, 2022 /PRNewswire/ -- Tethis S.p.A, a developer of a novel platform for liquid biopsy testing, announces the appointment of Mr Holger Neecke as the company's Chief Executive Officer.

Tethis S.p.A. Logo

Holger Neecke, Ph.D., MBA, is a molecular biologist with over 20 years of experience in the life sciences industry, specifically in pharma business development. He served as Head of the Technology Transfer Office at the AIRC Institute of Molecular Oncology (IFOM) in Milan and previously as Business Development Director at Adare Pharmaceuticals, Ablynx, and MolMed.
